Externally-Led Patient-Focused Drug Development (EL-PFDD) Meeting on DLB
October 15 @ 10:00 am - 3:00 pm EDT
It’s unanimous. Safe and effective drugs are urgently needed to treat dementia with Lewy bodies (DLB). Are you ready to make an impact on future treatments? Don’t miss this opportunity to share your lived experience with DLB with the FDA in this special, once-in-a-lifetime, public event. Your voice matters!
The Lewy Body Dementia Association in collaboration with the Alzheimer’s Association is bringing together the global community of people affected by dementia with Lewy bodies (DLB) for an important event called an Externally-Led Patient-Focused Drug Development (EL-PFDD) Meeting on DLB.
The EL-PFDD Meeting on DLB is a virtual, public event and open to anyone interested in increasing the understanding of DLB and improving treatments for those impacted by DLB including patients, their families and care partners and health care providers.
The meeting will be held on Tuesday, October 15, 2024 from 10:00am – 3:00pm ET.
Learn more about the EL-PFDD Meeting on DLB here: https://rb.gy/5bae4u
